J. Sullivan

发表

The clinical, economic, and humanistic burden of Dravet syndrome – A systematic literature review

S. Zuberi, J. Sullivan, A. Deighton, 2022, Epilepsy & Behavior.

Raising the bar: Fenfluramine sets new treatment standards for Dravet syndrome

J. Helen Cross, J. Sullivan, 2021, Epilepsy & Behavior.

Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy

J. Gécz, Debopam Samanta, R. Guerrini, 2023, Epilepsy Research.

Radiologic anatomy of the frontal sinus

R. Figueroa, J. Sullivan, 2005 .

Preventing Phenytoin-Induced Gingival Hyperplasia in Children

J. Sullivan, 2011 .

DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research

E. Wirrell, N. Huang, D. Bilder, 2021, Epilepsy & Behavior.

Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy

J. Gécz, Debopam Samanta, R. Guerrini, 2023, Epilepsy Research.

Fenfluramine Treatment Is Associated With Improvement in Everyday Executive Function in Adults With Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects From a Phase 3 Trial Rationale (P11-1.001)

I. Scheffer, G. Gioia, P. Isquith, 2023, Wednesday, April 26.

Fenfluramine Treatment Improves Everyday Executive Functioning in Patients with Lennox-Gastaut Syndrome: Analysis from a Phase 3 Clinical Trial

I. Scheffer, G. Gioia, B. Galer, 2021, Neuropediatrics.

Interim results of adaptive functioning and neurodevelopment in BUTTERFLY – An observational study of children and adolescents with Dravet syndrome

Kimberly A. Parkerson, E. Wirrell, Di Chen, 2022, Epilepsy & Behavior.